QuidelOrtho
QDEL
$85.54
Share price
0.97%
Change (1 day)
-17.31%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
P/S ratio for QuidelOrtho (QDEL)
P/S ratio as of May 2023 (TTM): 1.83
According to QuidelOrtho's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.83259. At the end of 2023 the company had a P/S ratio of 1.91.
P/S ratio history for QuidelOrtho from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.91 | 10.48% |
| 2022 | 1.73 | -47.71% |
| 2021 | 3.31 | -27.16% |
| 2020 | 4.55 | -22.56% |
| 2019 | 5.87 | 59.52% |
| 2018 | 3.68 | -30.62% |
| 2017 | 5.31 | 45.4% |
| 2016 | 3.65 | 0.94% |
| 2015 | 3.62 | -33.7% |
| 2014 | 5.45 | -9.12% |
| 2013 | 6.00 | 49.63% |
| 2012 | 4.01 | 26.43% |
| 2011 | 3.17 | -12.75% |
| 2010 | 3.64 | 49.31% |
| 2009 | 2.43 | -26.67% |
| 2008 | 3.32 | -38.44% |
| 2007 | 5.39 | 25.21% |
| 2006 | 4.31 | 8.99% |
| 2005 | 3.95 | 92.23% |
| 2004 | 2.06 | -40.29% |
| 2003 | 3.44 | 162.06% |
| 2002 | 1.31 | -56.4% |
| 2001 | 3.01 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.60 | 150.74% | 🇺🇸 USA |
 Becton Dickinson BDX | 3.64 | 98.88% | 🇺🇸 USA |
 Danaher DHR | 5.54 | 202.14% | 🇺🇸 USA |
 PerkinElmer
PKI | 3.67 | 100.10% | 🇺🇸 USA |
 OraSure Technologies OSUR | 0.9208 | -49.75% | 🇺🇸 USA |
 Meridian Bioscience VIVO | 4.47 | 143.96% | 🇺🇸 USA |